| Heart disease and stroke statistics—2013 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ... circulation 127 (1), e6-e245, 2013 | 78789* | 2013 |
| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The … G Hindricks, T Potpara, N Dagres, E Arbelo, JJ Bax, ... European heart journal 42 (5), 373-498, 2021 | 10942 | 2021 |
| Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial … GYH Lip, R Nieuwlaat, R Pisters, DA Lane, HJGM Crijns Chest 137 (2), 263-272, 2010 | 8249 | 2010 |
| A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey R Pisters, DA Lane, R Nieuwlaat, CB De Vos, HJGM Crijns, GYH Lip Chest 138 (5), 1093-1100, 2010 | 5684 | 2010 |
| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with … Authors/Task Force Members, SG Priori, C Blomström-Lundqvist, ... Ep Europace 17 (11), 1601-1687, 2015 | 5577 | 2015 |
| The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation J Steffel, P Verhamme, TS Potpara, P Albaladejo, M Antz, L Desteghe, ... European heart journal 39 (16), 1330-1393, 2018 | 3532 | 2018 |
| Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ... Ep Europace 17 (10), 1467-1507, 2015 | 1799 | 2015 |
| Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver … GYH Lip, L Frison, JL Halperin, DA Lane Journal of the American College of Cardiology 57 (2), 173-180, 2011 | 1358 | 2011 |
| Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice … JJ You, DE Singer, PA Howard, DA Lane, MH Eckman, MC Fang, ... Chest 141 (2), e531S-e575S, 2012 | 1289 | 2012 |
| Stroke and bleeding in atrial fibrillation with chronic kidney disease JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ... New England Journal of Medicine 367 (7), 625-635, 2012 | 1162 | 2012 |
| Quality of life in patients with atrial fibrillation: a systematic review G Thrall, D Lane, D Carroll, GYH Lip The American journal of medicine 119 (5), 448. e1-448. e19, 2006 | 1076 | 2006 |
| Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo, B Freedman, ... Chest 154 (5), 1121-1201, 2018 | 949 | 2018 |
| Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation … GYH Lip, L Frison, JL Halperin, DA Lane Stroke 41 (12), 2731-2738, 2010 | 695 | 2010 |
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a … Task Force Members, GYH Lip, S Windecker, K Huber, P Kirchhof, ... European heart journal 35 (45), 3155-3179, 2014 | 681 | 2014 |
| Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety D Lane, D Carroll, C Ring, DG Beevers, GYH Lip Psychosomatic medicine 63 (2), 221-230, 2001 | 646 | 2001 |
| Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ... Thrombosis and haemostasis 106 (10), 739-749, 2011 | 630 | 2011 |
| Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation DA Lane, GYH Lip Circulation 126 (7), 860-865, 2012 | 566 | 2012 |
| Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The … S Apostolakis, DA Lane, Y Guo, H Buller, GYH Lip Journal of the American College of Cardiology 60 (9), 861-867, 2012 | 511 | 2012 |
| Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis SL Harrison, E Fazio-Eynullayeva, DA Lane, P Underhill, GYH Lip PLoS medicine 17 (9), e1003321, 2020 | 496 | 2020 |
| The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe GYH Lip, CM Brechin, DA Lane Chest 142 (6), 1489-1498, 2012 | 476 | 2012 |
